Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs.
about
Genomic convergence among ERRα, PROX1, and BMAL1 in the control of metabolic clock outputsThe vitamin D receptor interacts preferentially with DRIP205-like LxxLL motifsEnergy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonistFasting-induced hepatic production of DHEA is regulated by PGC-1alpha, ERRalpha, and HNF4alphaBazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacyEstrogen-related receptor ERRα-mediated downregulation of human hydroxysteroid sulfotransferase (SULT2A1) in Hep G2 cells.The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.The NR3B subgroup: an ovERRviewOrphan nuclear receptors in breast cancer pathogenesis and therapeutic response.ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.The asymmetric binding of PGC-1α to the ERRα and ERRγ nuclear receptor homodimers involves a similar recognition mechanismSkeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease.Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.ERRalpha: a metabolic function for the oldest orphan.Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.The estrogen-related receptor alpha: the oldest, yet an energetic orphan with robust biological functions.The PGC-1/ERR signaling axis in cancer.The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases.Transrepressive function of TLX requires the histone demethylase LSD1.WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration.Modulation of estrogen related receptor alpha activity by the kinesin KIF17.Gene program-specific regulation of PGC-1{alpha} activity.Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growthRegulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin.Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency.Identification of differentially expressed three novel transcript variants of mouse ARNT gene.
P2860
Q21092423-E5B5EC70-4B4B-463F-9127-AF6CE77F5FE6Q24294517-BC1E71A3-1D23-4E4B-84CC-B3877BACCCC0Q28569816-89B162C3-6FBB-4470-ABE0-7723F31403AEQ28581621-E7322F07-A03A-4C66-AFB3-8A972C8E92CDQ30413295-DB69310E-1E96-4904-97CA-EF56999DD438Q33637010-F046F6A6-76D5-4727-8AFC-324DEEB24300Q33698278-90D31BED-0E08-447A-B244-E447CACAD072Q33772820-B2B7FE5B-C353-42A0-A882-572B74D70232Q35027844-1C353723-24F8-4605-9121-25B728A55A81Q35034228-B35A10B1-D067-4564-B349-AC4E5AB8EC7DQ35421284-20EBAFE5-5269-412C-8B9C-CFDA58ED37C1Q36238317-3341267D-4B19-461F-BE56-4FCEF3DDECB9Q36455407-3E56AB0A-C2A4-4B03-BE03-DF1BA2517611Q36803802-2235CAFF-3DCB-463C-9E01-9F101ACC94F7Q36944849-BBC3BA85-B245-42F5-AE94-2BC18DCBB6F8Q36996995-26D17DD0-2A43-48ED-994D-3FDF2FFCC61EQ37024621-3FDD12C7-13D8-489B-B9F1-972A60CCE565Q37079303-28838FD1-6211-4984-929B-32EF0F520D12Q37188645-CA0CAFC1-F5F8-445A-B15F-B1FD20C72C0DQ37263563-26F664C9-64A1-46D0-A2A3-6D5353D39B4DQ37565093-47B668BF-B61D-47FF-8E27-58B49F88CD8FQ37760219-C1E1CAB4-DE26-43CE-A879-62BB25B30522Q38064784-9B14C5EC-3CF5-4E35-8A9B-9999799D5891Q38286999-BBCE3EDD-3A9B-489D-B26D-06DB94040EDDQ39024215-D48B831A-4A11-457B-BC79-83EA8D6B6609Q39651531-AE252C8F-D9B7-4181-93FA-FDFE2FFBD71FQ41611988-528FDD23-2FA0-4B87-939D-76E3845FB2B2Q42060868-2AD3651C-16DE-47DF-9FD3-0E6EBFDE58B0Q42237844-4D31933F-658C-4CE5-812A-F9F73FE16E4EQ42924976-324C6670-B099-42A1-9503-36D5BD1465BCQ48882834-C8A56370-400C-452D-9B86-355BDE870478Q51561948-489C89C5-6235-438E-B6E9-620430BBE789
P2860
Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@ast
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@en
type
label
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@ast
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@en
prefLabel
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@ast
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@en
P2093
P4510
P1433
P1476
Receptor-selective coactivator ...... ic receptor-coactivator pairs.
@en
P2093
Ching-yi Chang
Christiane L Haeffele
Dmitri Kazmin
Donald P McDonnell
Edward K Lobenhofer
Linda L Grasfeder
Russ Wolfinger
Stéphanie Gaillard
Timothy R Koves
Tzu-Ming Chu
P304
P356
10.1016/J.MOLCEL.2006.10.012
P577
2006-12-01T00:00:00Z